top of page

Singapore’s Co-Developed Vaccine Candidate is in ‘Good Shape’ For Delivery in 2021

Positive interim results were announced by Singapore’s Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics in collaboration with scientists from the Duke-NUS Medical School in Singapore. Nice!

Photo credit: Pavel Danilyuk

5 views0 comments


bottom of page